Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Asahi Glass describes dual NK1/NK2 antagonists

May 12, 1999

Antiallergic/antiinflammatory agents in the Nikken Chemicals pipeline

May 11, 1999

New peptide tachykinin antagonists from Asahi Glass

May 11, 1999

Flixotide submitted for COPD in major markets

May 10, 1999

NA-00226B and C, produced by Streptomyces, inhibit cAMP PDE activity

May 10, 1999

Chugai and Dainippon Ink & Chemicals to codevelop new antiallergic agent

May 6, 1999

Alpha1-antitrypsin may be a future treatment for asthma

May 6, 1999

Progress in ARDS/ALI studies of lisofylline reported

May 6, 1999

Celltech reports new developments in the field of PDE4 inhibitors

May 5, 1999

Serine protease inhibitors designed at Glaxo Wellcome

May 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...